샘플 요청 목록

 카트 문의
시장보고서
상품코드
1631253

신장 기능 검사 시장 - 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2032년)

Renal Function Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 206 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 신장 기능 검사 시장 규모는 2025년부터 2032년까지 7.10%의 CAGR로 크게 성장할 것으로 예상됩니다. 이 시장은 진단의 발전과 신장 건강에 대한 인식이 높아짐에 따라 2025년 11억 3,000만 달러에서 2032년 18억 3,000만 달러로 확대될 것으로 예상됩니다. 신장 기능 검사(RFT)는 혈청 크레아티닌, 혈중 요소질소(BUN), 사구체여과율(GFR) 등의 파라미터를 분석하여 신장 건강 상태를 평가하는 데 필수적입니다. 이러한 검사는 만성콩팥병(CKD), 신부전, 요로감염 등의 병태 진단에 필수적이며, 적시에 개입하고 환자 치료를 개선할 수 있도록 도와줍니다.

전 세계적으로 만성 신장 질환의 유병률 증가와 인구 고령화가 신장 진단 약품에 대한 수요를 주도하고 있습니다. 자동화 시스템, 고처리량 기술 등의 기술 혁신은 RFT의 효율성과 정확성을 높이고 있습니다. 또한, 예방적 건강 관리 및 정기적인 신장 검진에 대한 인식이 높아지면서 시장 성장을 촉진하고 있습니다. 기계적으로는 혁신적인 바이오마커 개발, 보다 빠르고 편리한 진단을 제공하는 현장진단(POCT) 솔루션 등이 있습니다. 데이터 분석을 위한 인공지능(AI)의 통합은 정확한 진단과 개인화된 치료 계획을 가능하게함으로써 시장을 더욱 견인할 것으로 보입니다.

자동화된 고처리량 시스템은 신장 진단에 혁명을 일으켜 혈청 크레아티닌 및 GFR과 같은 파라미터를 보다 빠르고 정확하게 분석할 수 있게 해줍니다. 이러한 기술 혁신은 환자의 순응도를 향상시키고 시장 확대를 지원합니다.

인구의 고령화와 생활습관 관련 위험요인으로 인해 CKD의 부담이 증가함에 따라 정확한 진단 도구의 필요성이 증가하고 있습니다. 신장 기능 검사는 CKD의 발견과 관리에 필수적이며, 전 세계적으로 보급의 원동력이 되고 있습니다.

세계의 신장 기능 검사 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 검사 유형별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나·러시아 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 신장 기능 검사 시장 전망, 2019-2032년

  • 세계의 신장 기능 검사 시장 전망, 제품 유형별, 금액(10억 달러), 2019-2032년
  • 세계의 신장 기능 검사 시장 전망, 검사 유형별, 금액(10억 달러), 2019-2032년
  • 세계의 신장 기능 검사 시장 전망, 최종사용자별, 금액(10억 달러), 2019-2032년
  • 세계의 신장 기능 검사 시장 전망, 지역별, 금액(10억 달러), 2019-2032년

제4장 북미의 신장 기능 검사 시장 전망, 2019-2032년

제5장 유럽의 신장 기능 검사 시장 전망, 2019-2032년

제6장 아시아태평양의 신장 기능 검사 시장 전망, 2019-2032년

제7장 라틴아메리카의 신장 기능 검사 시장 전망, 2019-2032년

제8장 중동 및 아프리카의 신장 기능 검사 시장 전망, 2019-2032년

제9장 경쟁 구도

  • 제품 유형별과 검사 유형별 히트맵
  • 기업 시장 점유율 분석, 2024년
  • 경쟁 대시보드
  • 기업 개요
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers
    • Beckman Coulter(Danaher)
    • Abbott Laboratories Baxter International
    • Quest Diagnostic Incorporated
    • Sysmex Corporation
    • Laboratory Corporation of America Holdings(LabCorp
    • Randox Laboratories
    • ACON Laboratories
    • Arkray
    • Nova Biomedical
    • Idexx Laboratories
    • Elektronika
    • Cook Medical
    • VedaLab
    • Dx Gern Corp
    • Opti Medicals

제10장 부록

ksm 25.02.04

The global Renal Function Test Market is expected to grow significantly, with a CAGR of 7.10% from 2025 to 2032. The market is projected to expand from US$ 1.13 billion in 2025 to US$ 1.83 billion by 2032, driven by advancements in diagnostics and rising awareness of kidney health. Renal function tests (RFTs) are essential for evaluating kidney health by analyzing parameters like serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR). These tests are critical for diagnosing conditions such as chronic kidney disease (CKD), renal failure, and urinary tract infections, enabling timely intervention and improved patient care.

The increasing global prevalence of chronic kidney diseases and an aging population are driving demand for renal diagnostics. Innovations such as automated systems and high-throughput technologies enhance the efficiency and precision of RFTs. Additionally, growing awareness about preventive healthcare and routine renal screening is fueling market growth. Opportunities include the development of innovative biomarkers and point-of-care testing (POCT) solutions, which offer faster and more convenient diagnostics. The integration of artificial intelligence (AI) for data analysis is set to further drive the market by enabling precise diagnostics and personalized treatment plans.

Market Growth Drivers

1.Advancements in Diagnostic Technologies

Automated and high-throughput systems have revolutionized renal diagnostics, offering faster, more accurate analysis of parameters like serum creatinine and GFR. These innovations improve patient compliance and support market expansion.

2.Rising Prevalence of Chronic Kidney Diseases (CKD)

The growing burden of CKD, fueled by an aging population and lifestyle-related risk factors, underscores the need for accurate diagnostic tools. Renal function tests are vital for detecting and managing CKD, driving global adoption.

3.Increased Focus on Preventive Healthcare

Rising awareness of the importance of regular screenings has led to higher demand for routine renal function testing, enabling early detection and intervention.

Market Restraints

1.Pricing Competition and Limited Innovation

Market concentration among major players creates pricing challenges for smaller companies and may hinder innovation, limiting the diversity of available solutions.

2.Regulatory Hurdles and Compliance Issues

Stringent regulatory requirements for medical diagnostics increase development costs and delay product approvals, complicating the timely introduction of new solutions.

Business Opportunities

1.Innovative Biomarkers and Diagnostic Tools

Research into novel biomarkers offers enhanced accuracy and specificity for renal function tests. Companies focusing on these innovations can differentiate their offerings and address rising demand for advanced diagnostics.

2.Expansion of Point-of-Care Testing (POCT)

POCT solutions provide rapid and convenient diagnostics, particularly for clinics and home care. Developing portable, user-friendly devices for renal assessments can capture a growing market segment.

3.Integration of Artificial Intelligence

AI-powered data analysis improves precision and enables personalized treatment plans, providing a competitive advantage for companies leveraging these technologies.

Regional Analysis

1.Europe

Europe leads the renal function test market due to its robust healthcare infrastructure and high prevalence of renal disorders. The region's emphasis on quality and preventive healthcare drives widespread adoption of advanced renal diagnostics, while stringent regulatory standards ensure product reliability.

2.South Asia and Pacific

The South Asia and Pacific region is the fastest-growing market, driven by rising CKD prevalence, improved healthcare infrastructure, and increasing awareness of early diagnosis.

3.North America

North America remains a key market, supported by advanced healthcare systems, technological innovations, and growing demand for preventive diagnostics.

4.Latin America, Middle East, and Africa

Emerging economies in these regions offer significant growth potential, driven by expanding healthcare infrastructure and increasing awareness of renal health.

Competitive Analysis

Key players in the Renal Function Test Market include:

  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Beckman Coulter (Danaher)
  • Abbott Laboratories
  • Quest Diagnostics Incorporated
  • Sysmex Corporation
  • LabCorp
  • Randox Laboratories
  • ACON Laboratories
  • Arkray
  • Nova Biomedical
  • Idexx Laboratories
  • Elektronika
  • Cook Medical
  • VedaLab
  • Dx Gern Corp
  • Opti Medicals

These companies prioritize innovation, strategic partnerships, and customer-focused solutions to maintain their competitive edge.

Renal Function Test Market Segmentation

1.By Product Type

  • Dipsticks
  • Disposable
  • Reagents

2.By Test Type

  • Urine Tests
  • Blood Tests

3.By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Home Care Settings

4.By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Renal Function Test Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Renal Function Test Market Outlook, 2019 - 2032

  • 3.1. Global Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Dipsticks
      • 3.1.1.2. Disposable
      • 3.1.1.3. Reagents
  • 3.2. Global Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Urine
      • 3.2.1.2. Blood Test
  • 3.3. Global Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 3.3.1.2. Research Laboratories and Institutes
      • 3.3.1.3. Home Care Settings
  • 3.4. Global Renal Function Test Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Renal Function Test Market Outlook, 2019 - 2032

  • 4.1. North America Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Dipsticks
      • 4.1.1.2. Disposable
      • 4.1.1.3. Reagents
  • 4.2. North America Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Urine
      • 4.2.1.2. Blood Test
  • 4.3. North America Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 4.3.1.2. Research Laboratories and Institutes
      • 4.3.1.3. Home Care Settings
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. U.S. Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. U.S. Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Renal Function Test Market Outlook, 2019 - 2032

  • 5.1. Europe Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Dipsticks
      • 5.1.1.2. Disposable
      • 5.1.1.3. Reagents
  • 5.2. Europe Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Urine
      • 5.2.1.2. Blood Test
  • 5.3. Europe Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 5.3.1.2. Research Laboratories and Institutes
      • 5.3.1.3. Home Care Settings
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Renal Function Test Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Dipsticks
      • 6.1.1.2. Disposable
      • 6.1.1.3. Reagents
  • 6.2. Asia Pacific Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Urine
      • 6.2.1.2. Blood Test
  • 6.3. Asia Pacific Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 6.3.1.2. Research Laboratories and Institutes
      • 6.3.1.3. Home Care Settings
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Renal Function Test Market Outlook, 2019 - 2032

  • 7.1. Latin America Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Dipsticks
      • 7.1.1.2. Disposable
      • 7.1.1.3. Reagents
  • 7.2. Latin America Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Urine
      • 7.2.1.2. Blood Test
  • 7.3. Latin America Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 7.3.1.2. Research Laboratories and Institutes
      • 7.3.1.3. Home Care Settings
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Renal Function Test Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Renal Function Test Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Dipsticks
      • 8.1.1.2. Disposable
      • 8.1.1.3. Reagents
  • 8.2. Middle East & Africa Renal Function Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Urine
      • 8.2.1.2. Blood Test
  • 8.3. Middle East & Africa Renal Function Test Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals and Clinics Diagnostic laboratories
      • 8.3.1.2. Research Laboratories and Institutes
      • 8.3.1.3. Home Care Settings
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Renal Function Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Renal Function Test Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Renal Function Test Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Renal Function Test Market by End User, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product Type vs by Test Type Heat map
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. F. Hoffmann-La Roche Ltd.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Siemens Healthineers
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Beckman Coulter (Danaher)
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Abbott Laboratories Baxter International
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Quest Diagnostic Incorporated
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Sysmex Corporation
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Laboratory Corporation of America Holdings (LabCorp
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Randox Laboratories
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. ACON Laboratories
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Arkray
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Nova Biomedical
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Idexx Laboratories
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Elektronika
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Cook Medical
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. VedaLab
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development
    • 9.4.16. Dx Gern Corp
      • 9.4.16.1. Company Overview
      • 9.4.16.2. Product Portfolio
      • 9.4.16.3. Financial Overview
      • 9.4.16.4. Business Strategies and Development
    • 9.4.17. Opti Medicals
      • 9.4.17.1. Company Overview
      • 9.4.17.2. Product Portfolio
      • 9.4.17.3. Financial Overview
      • 9.4.17.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제